U-LABA/ICS Effects on Exercise Performance, Formoterol
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the project is to investigate exercise performance in well-trained individuals
in a crossover design following varying degrees of bronchodilation/constriction intervention
using current standard procedures.
Phase:
N/A
Details
Lead Sponsor:
Morten Hostrup, PhD
Treatments:
Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate Mannitol